• Humana signed a definitive agreement to divest all or substantially all of its minority interest in end-of-life care provider Gentiva.
• The deal values the stake at about USD 900 million.
• Proceeds earmarked for general corporate purposes.
• Closing expected in Q3 2026, subject to regulatory approvals and customary conditions.
• Humana does not expect the pending transaction to have a material impact on 2026 earnings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humana Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260610493628) on June 10, 2026, and is solely responsible for the information contained therein.